JAK1 and autoimmune disease: Since, JAK1 associated inflammatory cytokine signaling pathways are critical to the development of many autoimmune diseases (4), future studies are warranted to explore hsa-miR-127-3p’s therapeutic effects on LN or other autoimmune disease related organ damages with abnormal upregulation of JAK1.